RMDI
XBI icon

R.M. Davis Inc’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

R.M. Davis Inc’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36M Sell
8,597
-93
-1% -$12.6K 0.02% 138
2026
Q1 		$1.11M Sell
8,690
-652
-7% -$81.4K 0.02% 145
2025
Q4 		$1.14M Sell
9,342
-673
-7% -$77.2K 0.02% 146
2025
Q3 		$1M Sell
10,015
-2,194
-18% -$198K 0.02% 155
2025
Q2 		$1.01M Sell
12,209
-5,458
-31% -$435K 0.02% 157
2025
Q1 		$1.43M Sell
17,667
-5,972
-25% -$534K 0.03% 132
2024
Q4 		$2.13M Sell
23,639
-2,859
-11% -$277K 0.04% 123
2024
Q3 		$2.62M Sell
26,498
-2,083
-7% -$205K 0.05% 114
2024
Q2 		$2.65M Sell
28,581
-6,879
-19% -$617K 0.05% 112
2024
Q1 		$3.36M Sell
35,460
-3,292
-8% -$305K 0.07% 101
2023
Q4 		$3.46M Sell
38,752
-8,975
-19% -$667K 0.08% 103
2023
Q3 		$3.48M Sell
47,727
-6,421
-12% -$513K 0.09% 108
2023
Q2 		$4.5M Sell
54,148
-1,437
-3% -$120K 0.11% 104
2023
Q1 		$4.24M Sell
55,585
-7,363
-12% -$611K 0.11% 103
2022
Q4 		$5.22M Sell
62,948
-4,209
-6% -$341K 0.14% 99
2022
Q3 		$5.33M Sell
67,157
-3,901
-5% -$329K 0.15% 101
2022
Q2 		$5.28M Sell
71,058
-13,254
-16% -$995K 0.15% 101
2022
Q1 		$7.58M Sell
84,312
-18,038
-18% -$1.67M 0.18% 99
2021
Q4 		$11.5M Sell
102,350
-15,839
-13% -$1.91M 0.26% 95
2021
Q3 		$14.9M Sell
118,189
-2,944
-2% -$379K 0.37% 83
2021
Q2 		$16.4M Buy
121,133
+12,761
+12% +$1.68M 0.41% 80
2021
Q1 		$14.7M Buy
108,372
+9,676
+10% +$1.45M 0.4% 78
2020
Q4 		$13.9M Buy
98,696
+34,966
+55% +$4.48M 0.4% 72
2020
Q3 		$7.1M Buy
63,730
+44,178
+226% +$4.95M 0.23% 94
2020
Q2 		$2.19M Buy
+19,552
New +$1.93M 0.08% 109

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

R.M. Davis Inc's XBI Position: Q2 2026 in Review

R.M. Davis Inc reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 1.1% in Q2 2026, selling an estimated $12.6K and leaving 8,597 shares worth $1.36M. The position accounts for 0.02% of the portfolio, ranked #138.

R.M. Davis Inc first reported a position in XBI in Q2 2020 and has held it in 25 quarters since. The position peaked at $16.4M in Q2 2021. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • R.M. Davis Inc held 8,597 shares of State Street SPDR S&P Biotech ETF worth $1.36M as of Q2 2026.
  • R.M. Davis Inc sold 93 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $12.6K.
  • State Street SPDR S&P Biotech ETF made up 0.02% of R.M. Davis Inc's portfolio in Q2 2026, its #138 holding.
  • R.M. Davis Inc first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and has held it in 25 quarters since.
  • R.M. Davis Inc's State Street SPDR S&P Biotech ETF position peaked at $16.4M in Q2 2021.
  • 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on R.M. Davis Inc's 13F filing for Q2 2026, filed 14 Aug 2026.